FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed…
Oncology
The most expensive one percent: A case study
What would you do? Let author Leah Curtin know after you read this case study.
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate…
National Magnet Nurse of the Year™ 2012 award winners
The National Magnet Nurse of the Year™ awards from the American Nurses Credentialing Center (ANCC) recognize the outstanding contributions of clinical nurses in each…
Consider a career in clinical research
Nurses are taking on a range of unique and challenging roles in the clinical research field.
A probable meningitis case puts the ED on alert
The care team works quickly to identify the patient’s meningitis type.
Issues up close
Genomic science has crossed the horizon of health care into our everyday lives, transforming our understanding of health and illness. The era of personalized…
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous leukemia. Synribo…
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease…
The most expensive one percent: A case study
What would you do? Let author Leah Curtin know after you read this case study.
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
Helping patients survive sepsis
In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.
FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic…
National Magnet Nurse of the Year™ 2012 award winners
The National Magnet Nurse of the Year™ awards from the American Nurses Credentialing Center (ANCC) recognize the outstanding contributions of clinical nurses…
Consider a career in clinical research
Nurses are taking on a range of unique and challenging roles in the clinical research field.
A probable meningitis case puts the ED on alert
The care team works quickly to identify the patient’s meningitis type.
Issues up close
Genomic science has crossed the horizon of health care into our everyday lives, transforming our understanding of health and illness. The era…
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous…
Test Your Knowledge
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.